Tonix Pharmaceuticals Holding Corp. (TNXP) is a publicly traded Healthcare sector company. As of July 13, 2026, TNXP trades at $11.96 with a market cap of $199.74M and a P/E ratio of -0.88. TNXP moved -4.39% today. Year to date, TNXP is -20.80%; over the trailing twelve months it is -70.42%. Its 52-week range spans $6.76 to $130.00. Analyst consensus is strong buy with an average price target of $37.67. Rallies surfaces TNXP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TNXP insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $11.96 |
| Market Cap | $199.74M |
| P/E Ratio | -0.88 |
| EPS | $-14.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $130.00 |
| 52-Week Low | $6.76 |
| Volume | 347.38K |
| Avg Volume | 0 |
| Revenue (TTM) | $13.11M |
| Net Income | $-124.02M |
| Gross Margin | 49.34% |
3 analysts cover TNXP: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $37.67.